Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cancer Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cancer Genetics Inc (CGIX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Sep 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for CGIX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

CANCER GENETICS INC (CGIX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Wright Investors Service Comprehensive Report for Cancer Genetics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Sep 2016 Wright Reports 64 $75.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company that...

12 Sep 2016 GlobalData 63 $300.00

Cancer Genetics Inc: Downgraded to Below Average

06 Sep 2016 Sadif Analytics Prime 3 $10.00

CGIX- Q2 revenue and EPS better than expectations, I-O aids backlog growth

Q2 revenue and EPS better than expectations, I-O aids backlog growth

11 Aug 2016 Feltl & Company 8 $81.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company that...

16 Jun 2016 GlobalData 60 $300.00

CGIX- Q1 revenue missed, lowering estimates, but immuno-oncology heating up

Q1 revenue missed, lowering estimates, but immuno-oncology heating up

11 May 2016 Feltl & Company 9 $81.00